Keyphrases
Schizophrenia
100%
Bipolar Disorder
100%
Autoimmunity
100%
B Cell Activating Factor
100%
Inflammatory Biomarkers
100%
Schizophrenia Symptoms
66%
Healthy Controls
33%
Central Nervous System
22%
Schizophrenic Patients
22%
Genotype
22%
Autoantibodies
22%
3′-untranslated Region (3′-UTR)
22%
Acute Episodes
22%
Circulating Levels
22%
Diagnostic Tool
11%
Clinical Characteristics
11%
Monoclonal Antibody
11%
Disease Risk
11%
Polymorphism
11%
Pathophysiology
11%
Stable Patients
11%
Herpes Simplex Virus Type 1 (HSV-1)
11%
Autoimmune Process
11%
Insertion-deletion
11%
Prognostic Tool
11%
Treatment Options
11%
Humoral Immune Response
11%
Clinical High Risk
11%
B Lymphocytes
11%
Immunotherapeutics
11%
System Structure
11%
Physical Abuse
11%
Inflammatory Markers
11%
Insertion Polymorphism
11%
Clinical Utility
11%
Immune Dysregulation
11%
Predictive Tool
11%
Immunoglobulin G Antibodies
11%
Predictive Diagnostics
11%
Global Functioning
11%
Disorder Control
11%
TNFSF13B
11%
Childhood History
11%
Childhood Trauma
11%
Potential Correlation
11%
Inflammatory Molecules
11%
Positive Psychotic Symptoms
11%
Genotype Distribution
11%
Predictive Prognostics
11%
PANSS
11%
Infectious Events
11%
Systemic Autoantibodies
11%
Neuroscience
Dementia Praecox
100%
Bipolar Disorder
100%
B Cell Activating Factor
100%
Autoantibodies
15%
Central Nervous System
10%
Indel Mutation
10%
Immunoglobulin G Antibody
5%
Herpes Simplex Virus
5%
Monoclonal Antibody
5%
Humoral Immunity
5%
B Cell
5%
Pediatric Trauma
5%
Immunology and Microbiology
Autoimmunity
100%
B Cell Activating Factor
100%
Autoantibodies
15%
Indel Mutation
10%
Central Nervous System
10%
Monoclonal Antibody
5%
B Cell
5%
Human Alphaherpesvirus 1
5%
Humoral Immunity
5%
Immunoglobulin G Antibody
5%
Immune Dysregulation
5%
Biochemistry, Genetics and Molecular Biology
Autoimmunity
100%
B-Cell Activating Factor
100%
Autoantibodies
15%
Indel
10%
Genotyping
5%
B Cell
5%
Monospecific Antibody
5%
Monoclonal Antibody
5%
Human Alphaherpesvirus 1
5%
Humoral Immunity
5%
Immunoglobulin G
5%